2022 Completed US FDA, EMA, and MHRA regulatory audits for biologics manufacturing facility 2022 Published Syngene’s first Environment Social Governance (ESG) report 2021 Signed a 10-year agreement with Zoetis for commercial manufacturing of Librela®, a first-of-its-kind monoclonal antibody to ...